Qfitlia (Fitusiran)

FDA has approved new drug Qfitlia (fitusiran) for treating hemophilia A and B.

It mainly works by reducing the antithrombin levels, leading to an increase in thrombin levels, a protein essential for blood clotting.

Qfitlia improves blood clotting in patients with bleeding disorders - Hemophilia A and B.

4 Likes

Thanks

2 Likes

Oh that’s great it work as a anticoagulant and also helps in the case of hemophilia A and B that’s great

2 Likes

Very interesting.

2 Likes

Nice. Thank you for sharing the info.

1 Like